Julius Knowles - 04 Jun 2021 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
04 Jun 2021
Net transactions value
-$952,613
Form type
4
Filing time
08 Jun 2021, 16:31:34 UTC
Previous filing
03 Jun 2021
Next filing
06 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Sale $141,123 -2,988 -0.54% $47.23 552,227 04 Jun 2021 See footnote F1, F2, F3
transaction KROS Common Stock Sale $92,098 -1,950 -0.52% $47.23 370,109 04 Jun 2021 See footnote F1, F2, F4
transaction KROS Common Stock Sale $49,017 -1,018 -0.18% $48.15 551,209 04 Jun 2021 See footnote F1, F3, F5
transaction KROS Common Stock Sale $31,923 -663 -0.18% $48.15 369,446 04 Jun 2021 See footnote F1, F4, F5
transaction KROS Common Stock Sale $32,675 -703 -0.13% $46.48 550,506 07 Jun 2021 See footnote F1, F3, F6
transaction KROS Common Stock Sale $21,334 -459 -0.12% $46.48 368,987 07 Jun 2021 See footnote F1, F4, F6
transaction KROS Common Stock Sale $37,209 -786 -0.14% $47.34 549,720 07 Jun 2021 See footnote F1, F3, F7
transaction KROS Common Stock Sale $24,238 -512 -0.14% $47.34 368,475 07 Jun 2021 See footnote F1, F4, F7
transaction KROS Common Stock Sale $27,306 -560 -0.1% $48.76 549,160 07 Jun 2021 See footnote F1, F3, F8
transaction KROS Common Stock Sale $17,846 -366 -0.1% $48.76 368,109 07 Jun 2021 See footnote F1, F4, F8
transaction KROS Common Stock Sale $43,517 -870 -0.16% $50.02 548,290 07 Jun 2021 See footnote F1, F3, F9
transaction KROS Common Stock Sale $28,411 -568 -0.15% $50.02 367,541 07 Jun 2021 See footnote F1, F4, F9
transaction KROS Common Stock Sale $201,574 -3,968 -0.72% $50.80 544,322 07 Jun 2021 See footnote F1, F3, F10
transaction KROS Common Stock Sale $131,369 -2,586 -0.7% $50.80 364,955 07 Jun 2021 See footnote F1, F4, F10
transaction KROS Common Stock Sale $44,153 -858 -0.16% $51.46 543,464 07 Jun 2021 See footnote F1, F3, F11
transaction KROS Common Stock Sale $28,818 -560 -0.15% $51.46 364,395 07 Jun 2021 See footnote F1, F4, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.90 to $47.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8), (9), (10) and (11).
F3 The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
F4 The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.90 to $48.57 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.89 to $46.83 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.89 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.25 to $49.24 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.28 to $50.27 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.28 to $51.265 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.31 to $51.80 inclusive.